Teachers Retirement System of The State of Kentucky Invests $4.17 Million in Tempus AI, Inc. (NASDAQ:TEM)

Teachers Retirement System of The State of Kentucky purchased a new stake in Tempus AI, Inc. (NASDAQ:TEM) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 119,000 shares of the company’s stock, valued at approximately $4,165,000. Teachers Retirement System of The State of Kentucky owned 0.07% of Tempus AI as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Novo Holdings A S bought a new stake in Tempus AI during the 2nd quarter valued at $142,605,000. Perceptive Advisors LLC purchased a new position in shares of Tempus AI in the second quarter valued at $9,625,000. Scientech Research LLC purchased a new position in shares of Tempus AI in the second quarter valued at $756,000. Sculptor Capital LP bought a new stake in shares of Tempus AI during the 2nd quarter valued at $5,085,000. Finally, The Manufacturers Life Insurance Company purchased a new stake in Tempus AI during the 2nd quarter worth about $946,000.

Tempus AI Stock Down 3.4 %

Shares of NASDAQ:TEM opened at $51.25 on Thursday. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $77.00. The stock has a fifty day moving average of $50.15.

Tempus AI (NASDAQ:TEM) last announced its earnings results on Tuesday, August 6th. The company reported ($6.77) earnings per share (EPS) for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The company had revenue of $165.97 million for the quarter, compared to the consensus estimate of $159.10 million. Sell-side analysts predict that Tempus AI, Inc. will post -6.51 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Morgan Stanley initiated coverage on Tempus AI in a research report on Tuesday, July 9th. They set an “overweight” rating and a $44.00 price target on the stock. Stifel Nicolaus assumed coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They issued a “buy” rating and a $45.00 target price on the stock. Needham & Company LLC restated a “buy” rating and set a $47.00 price target on shares of Tempus AI in a research report on Wednesday, August 7th. JPMorgan Chase & Co. boosted their price target on shares of Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Finally, Bank of America lowered shares of Tempus AI from a “buy” rating to a “neutral” rating and boosted their price target for the company from $45.00 to $60.00 in a research report on Wednesday. Two analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $47.67.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.